A Construction That Eliminates the Entire Scope of Dependent Claims Should Be Avoided -
Littelfuse, Inc. v. Mersen USA Ep Corp., Appeal No. 21-2013, the Federal Circuit vacated a claim construction that violated the doctrine...more
Claim Limitation Not Disclosed by Any Reference but Disclosed by “Proposed Combination” of References Is Obvious -
In Hoyt Augustus Fleming v. Cirrus Design Corporation, Appeal No. 21-1561, the Federal Circuit held that a...more
4/5/2022
/ Anticipation ,
Claim Construction ,
Claim Limitations ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Motion to Amend ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Sua Sponte ,
Substitute Claims
避而不谈可能支持否定性权利要求限定 -
在 Novartis Pharmaceuticals 诉 Accord Healthcare Inc. 一案（上诉案件编号：21- 1070）中，联邦巡回上诉法院认为，一项对药物“速效剂量”避而不谈的专利申请，为要求不存在此类剂量的否定 性权利要求限制提供了书面说明支持。
...more
2/10/2022
/ Claim Construction ,
Indefiniteness ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
記述がないことがクレームの否定的限定のサポートと解釈できる場合がある
Federal Circuit は、Novartis Pharmaceuticals v. Accord Healthcare Inc. (Appeal No. 21-1070) に おいて、薬剤の「初回負荷用量」についての記述がない特許出願は、そのような用量がないことを要 求するクレームの否定的限定に記述によるサポートを提供していることになると判示した。
...more
2/10/2022
/ Claim Construction ,
Indefiniteness ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
January 2022 Federal Circuit Newsletter (Japanese) January 2022 Federal Circuit Newsletter (Chinese) Silence May Support Negative Claim Limitation In Novartis Pharmaceuticals v. Accord Healthcare Inc. Appeal No. 21-1070, the...more
2/9/2022
/ Claim Construction ,
Indefiniteness ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
Venue and Pleading Infringement in Hatch-Waxman Litigation Turn on Location and Identity of ANDA Filer -
In Celgene Corp. v. Mylan Pharm. et al., Appeal No. 21-1154, the Federal Circuit held that in Hatch-Waxman...more
12/9/2021
/ Abbreviated New Drug Application (ANDA) ,
Apple ,
Article III ,
Biogen Idec ,
Dr. Reddy’s Labs. ,
Generic Drugs ,
Hatch-Waxman ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Mylan Pharmaceuticals ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Qualcomm ,
Standing ,
Written Descriptions
No Assembly, No Infringement – Federal Circuit Declines to Expand the “Final Assembler” Theory of Direct Infringement
In Acceleration Bay LLC v. Take-Two Interactive Software, Appeal No. 20-1700 the Federal Circuit held that...more
11/9/2021
/ Abstract Ideas ,
CLS Bank v Alice Corp ,
Computer-Related Inventions ,
Direct Infringement ,
Gaming ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Software
Arguments to the Patent Office That Contradict Information Submitted to the FDA Support an Inference of Deceptive Intent
In Belcher Pharmaceuticals v. Hospira, Inc., Appeal No. 20-1799, the Federal Circuit held that a...more
10/6/2021
/ Deceptive Intent ,
Evidence ,
Failure To Disclose ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Hospira ,
Inequitable Conduct ,
Intellectual Property Protection ,
Motion to Transfer ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Patents ,
Pharmaceutical Patents ,
Post-Grant Review ,
Prior Art ,
USPTO ,
Venue
District Court’s Pleading Standard Returns an Error Code in PS4 Battle -
In Bot M8 LLC v. Sony Corporation Of America, Appeal No. 20-2218, the Federal Circuit held that the district court’s view that infringement...more
8/18/2021
/ Amended Complaints ,
Claim Construction ,
Failure To State A Claim ,
Gaming ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pleading Standards ,
Prior Art ,
Qualcomm ,
Sony ,
Sua Sponte
Bulk-Filed Patent Applications Claiming Distant Priority Trigger Prosecution Laches -
In Hyatt v. Hirshfeld, Appeal No. 18-2390, the Federal Circuit held that the PTO met its burden to prove prosecution laches for bulk-filed...more
7/28/2021
/ Amazon Marketplace ,
Antitrust Provisions ,
Apple ,
Assignor Estoppel ,
Claim Construction ,
Compensation ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventions ,
Laches ,
NCAA ,
Patent Applications ,
Patent Infringement ,
Patents ,
Prior Art ,
Standalone Authority ,
Subject Matter Jurisdiction ,
USPTO ,
Venue
Grammar School: District Court Erred in Departing from Claim Language to Adopt Construction that Encompassed All Disclosed Embodiments -
In Simo Holdings Inc. v. Hong Kong Ucloudlink Network, Appeal No.19-2411, the...more
Non-Disclosure Agreement Controls Ownership of Patents Arising From Confidential Information Received Thereunder -
In Sionyx LLC v. Hamamatsu Photonics K.K., Appeal No. 19-2359, the Federal Circuit held that a party who...more
Secret Third-Party Processes May Not Trigger Pre-AIA § 102 Public Knowledge or Use Bars -
In Basf Corporation v. SNF Holding Company, Appeal No. 19-1243, the Federal Circuit ruled that a third party’s sale of products...more
Specification’s Narrow Description of the Invention Results in Disavowal of Claim Scope -
In Techtronic Industries Co. Ltd. v. ITC., Appeal No. 18-2191, the consistent description in the specification of a particular...more
1/27/2020
/ Administrative Law Judge (ALJ) ,
Exceptional Case ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
New Evidence ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art